Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

for
Coronary Artery Disease
Location: Nashville TN, Marietta GA, Atlanta GA, Cincinnati OH,
Sponsor: Minneapolis Heart Institute Foundation

Sex: All

Age: 0+

Code: NCT02061436

Recruiting

The PERSEVERE Study

for
Pulmonary Embolism, Pulmonary Thromboembolism
Location: Nashville TN, Atlanta GA, Jackson MS, Akron OH,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT06588634

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Nashville TN, Columbus OH, Chapel Hill NC,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase 1, Phase 2, Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Nashville TN, Columbus OH, Winston-Salem NC,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase 1, Phase 2, Recruiting

A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
Location: Nashville TN, Birmingham AL, Augusta GA,
Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 18+

Code: NCT06163430

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Nashville TN, Birmingham AL, Tupelo MS, Decatur GA,
Sponsor: Concept Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT05908331

Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Nashville TN, Grand Rapids MI, Tampa FL, Houston TX,
Sponsor: Prelude Therapeutics Incorporated

Sex: All

Age: 18+

Code: NCT07469891

Phase 1, Recruiting

The ArtixASCEND Study

for
Acute Lower Limb Arterial Occlusion
Location: Nashville TN, Asheville NC, Cincinnati OH,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT07135895

Recruiting

BoxX-NoAF Clinical Trial

for
Post Operative Atrial Fibrillation,
Location: Nashville TN, Marietta GA, Louisville KY, Atlanta GA,
Sponsor: AtriCure, Inc.

Sex: All

Age: 65+

Code: NCT06989775

Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: Nashville TN, Atlanta GA, Toronto, Coral Springs FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase 1, Recruiting

ELEVATE High-Risk PCI Pivotal Study

for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Location: Nashville TN, Marietta GA, Atlanta GA, Edgewood KY,
Sponsor: Magenta Medical Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07001332

Recruiting

HPC Offered for PRESERVE Expansion

for
Bone Marrow Transplant (BMT)
Location: Nashville TN, Birmingham AL, Columbus OH, Detroit MI
Sponsor: Ossium Health, Inc.

Sex: All

Age: 12 - 70+

Code: NCT07145411

Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for
Obstructive Hypertrophic Cardiomyopathy
Location: Nashville TN, Tupelo MS, Greenville SC, Cincinnati OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05489705

Recruiting

Delirium Reduction With Ramelteon

for
Delirium
Location: Nashville TN
Sponsor: Centennial Medical Center

Sex: All

Age: 18+

Code: NCT05069428

Recruiting

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

for
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Location: Nashville TN, Cincinnati OH, Detroit MI, Rochester MN,
Sponsor: Innoventric LTD

Sex: All

Age: 18 - 70+

Code: NCT06212193

Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Nashville TN, Louisville KY, Greenville SC, Chicago IL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase 1, Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Nashville TN, Birmingham AL, Cincinnati OH, Houston TX,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase 1, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Nashville TN, Louisville KY, Atlanta GA, Augusta GA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Nashville TN, Urbana IL, Chicago IL, Zion IL,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase 1, Phase 2, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Atlanta GA, St Louis MO, Columbus OH,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting